Glynnis Thatch, NP
Family · Fishers, INNPI 1366466492
Payments from drug & device makers
Across 83 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$573
- Lilly USA, LLC$169
- Pfizer$152
- Exact Sciences$105
- Astellas Pharma US Inc$98
- Abbott$83
- plus $457 from 15 others
What the payments were for
- Food & beverage$1,638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $573 |
| Lilly USA, LLC | 9 | $169 |
| Pfizer | 9 | $152 |
| Exact Sciences | 6 | $105 |
| Astellas Pharma US Inc | 5 | $98 |
| Abbott | 4 | $83 |
| AbbVie | 4 | $83 |
| Ironshore Pharmaceuticals Inc. | 3 | $63 |
| GSK | 3 | $49 |
| Corium, LLC | 2 | $39 |
| Shield Therapeutics Inc | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Edwards Lifesciences | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Novartis | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Merck | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
How this compares
$1,638 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 11 | $325 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $304 |
| Atorvastatin Calcium | 37 | $187 |
| Omeprazole | 29 | $181 |
| Amlodipine Besylate | 14 | $127 |
| Escitalopram Oxalate | 13 | $89 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $80 |
| Levothyroxine Sodium | 19 | $72 |
| Metformin Hcl ErMetformin Hcl | 12 | $56 |
| Losartan Potassium | 14 | $33 |
| Metformin Hcl | 13 | $27 |
| Hydrochlorothiazide | 17 | $20 |
Paid to pharmacies, not to this prescriber.
Other family in Fishers
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.